Abstract: A gas sensor includes a sensor element including an element body, a measurement pump cell including an inner measurement electrode, an adjustment pump cell including an inner adjustment electrode and a reference electrode, a control apparatus that performs an adjustment pump control process of adjusting the oxygen concentration in the oxygen concentration adjustment chamber so that an adjustment voltage reaches an adjustment voltage target value, and a measurement pump control process of pumping out oxygen in the measurement chamber so that a measurement voltage reaches a measurement voltage target value. The control apparatus detects the specific gas concentration in the measurement-object gas based on a measurement pump current, and the control apparatus detects a water concentration in the measurement-object gas based on a change in the measurement pump current when at least one of the adjustment voltage target value or the measurement voltage target value is changed.

Abstract: The present invention provides a method for treatment or prevention of cancer through novel action mechanism, namely, through inhibition of a riboflavin pathway. The method for treatment or prevention of cancer comprises administering an RF pathway inhibitor to a subject in need thereof.

Abstract: A battery frame is fixed to a chassis and a battery pack is assembled to the battery frame. The battery frame includes a pair of crossbars and a pair of side bars. The crossbars extend in the vehicle width direction while being spaced apart in the vehicle front-rear direction, and have both ends in the vehicle width direction fixed to the side members. The side bars extend in the vehicle front-rear direction while being spaced apart in the vehicle width direction, and have front ends and rear ends detachably fixed to the crossbars.

Abstract: There are provided a gas supply apparatus and a gas supply method that are capable of supplying hydrogen gas of a highly accurate and stable hydrogen gas concentration to a body. A ventilator 100 that supplies oxygen-containing gas and hydrogen gas includes a hydrogen gas delivery unit 8 that delivers the hydrogen gas taken in to outside of the ventilator 100, and a control unit 22 that adjusts an amount of the hydrogen gas taken into the hydrogen gas delivery unit 8. The control unit 22 adjusts the amount of the hydrogen gas taken into the hydrogen gas delivery unit 8 based on a flow rate of the oxygen-containing gas.

Abstract: A server (20) as an information presentation device according to the present disclosure includes a route search unit (23) that searches for the moving route, and a route information forming unit (24) as an information presentation unit that, in a case where the searched moving route includes a plurality of partial routes having different moving means, adds congestion information regarding a congestion status of the moving route as a whole according to a congestion degree of each of the plurality of partial routes to the moving route and presents the congestion information to the user.

Abstract: Provided is a composition for improving symptoms of organ-specific autoimmune diseases. A composition comprising a hydrogen gas-containing gas as an active ingredient, for use in improving symptoms caused by an organ-specific autoimmune disease and/or reducing worsening of the symptoms in patients with an organ-specific autoimmune disease, and a method for improving symptoms including a decrease in activity levels involved in symptoms of an organ-specific autoimmune disease and/or reducing worsening of the symptoms by administering the composition to patients with the organ-specific autoimmune disease.

Abstract: Provided is a novel composition that has no side effects and can be easily produced, for use in improving symptoms of sequelae of viral infection. A composition comprising a hydrogen gas-containing gas as an active ingredient, for use in improving symptoms of sequelae of viral infection, such as pulmonary fibrosis, feeling of fatigue, malaise, shortness of breath, difficulty breathing, and/or decrease in activity levels associated with these symptoms, in a patient with sequelae of viral infection, and/or a method for improving symptoms, such as decrease in activity levels associated with these symptoms.

Abstract: The present invention provides a composition for preventing or improving human osteoporosis, comprising molecular hydrogen as an active ingredient. More specifically, the present invention provides a composition for preventing or improving human osteoporosis, wherein the human osteoporosis is primary osteoporosis and/or secondary osteoporosis.

Abstract: The present invention provides a composition for maintaining a lung function in a human lung cancer and/or improving a reduction in lung function attributed to the human lung cancer. More specifically, the present invention provides a composition for maintaining a lung function in a human lung cancer and/or improving a reduction in lung function attributed to the human lung cancer in a subject, comprising molecular hydrogen as an active ingredient.

Abstract: The present invention provides a composition for prevention and/or improvement of an adverse drug reaction, a symptom associated with an adverse drug reaction, and/or an adverse reaction associated with medical treatment. More specifically, the present invention provides a composition for prevention and/or improvement of an adverse drug reaction, a symptom associated with an adverse drug reaction, and/or an adverse reaction associated with medical treatment in a subject, comprising molecular hydrogen as an active ingredient.

Abstract: The present application provides a composition for treatment or prophylaxis of age-related macular degeneration in a subject, comprising molecular hydrogen as an active ingredient, and a method for treatment or prophylaxis of age-related macular degeneration, comprising administering the composition to a subject with age-related macular degeneration.

Abstract: The present invention provides a composition for prevention and/or improvement of encephalitis and/or meningitis. More specifically, the present invention provides a composition for prevention and/or improvement of encephalitis and/or meningitis and a symptom associated with the encephalitis and/or meningitis in a subject, comprising molecular hydrogen as an active ingredient.

Abstract: The present invention provides a composition for prevention and/or improvement of a genetic disorder. More specifically, the present invention provides a composition for prevention and/or improvement of a genetic disorder and a symptom associated with the genetic disorder in a subject, comprising molecular hydrogen as an active ingredient.

Abstract: The present invention provides a composition for regulating intracellular signal transduction. More specifically, the present invention provides a composition for prevention and/or improvement of a symptom associated with intracellular signal transduction in a subject, comprising molecular hydrogen as an active ingredient.

Abstract: The present invention provides a composition for prevention and/or improvement of pneumonia. More specifically, the present invention provides a composition for prevention and/or improvement of pneumonia and a symptom associated with pneumonia in a subject, comprising molecular hydrogen as an active ingredient.

Abstract: The present invention provides a composition for prevention and/or improvement of inflammatory bowel disease. More specifically, the present invention provides a composition for prevention and/or improvement of inflammatory bowel disease and a symptom associated with inflammatory bowel disease in a subject, comprising molecular hydrogen as an active ingredient.

Abstract: The present invention provides a method or a composition for promotion of improvement of postoperative recovery. More specifically, the present invention provides a composition for promotion of recovery from or improvement of surgical invasion and/or a symptom associated with a surgery in a subject undergoing the surgery, comprising molecular hydrogen as an active ingredient, and a method for promotion of recovery from or improvement of surgical invasion and/or a symptom associated with a surgery in a subject undergoing the surgery, comprising administering a composition comprising molecular hydrogen as an active ingredient to the subject.

Abstract: The present application provides a composition for improving a symptom of spine/spinal cord injury in a subject, the composition comprising molecular hydrogen as an active ingredient; and a method for improving a symptom of spine/spinal cord injury in a subject, the method comprising administering the composition to the subject.

Abstract: This application provides a composition for ameliorating a post-cerebral stroke sequela in a human, comprising molecular hydrogen as an active ingredient, and a method for ameliorating a post-cerebral stroke sequela, comprising administering the composition to a human having a post-cerebral stroke sequela.

Abstract: The present application provides a composition for improving depressive symptoms in a human, comprising hydrogen as an active ingredient, and a method for improving depressive symptoms in a human having depressive symptoms, comprising administering the composition to the human.